Upregulated PXDNL promotes invasive breast carcinoma progression

Overexpression of PXDNL is associated with poor prognosis and is linked to immune cell infiltration in BRCA. Thus, PXDNL may be a biomarker or therapeutic target for BRCA.

Authors

Institutions

Publication Details

Journal
American Journal of Translational Research
Published
2025-01-01
DOI
https://doi.org/10.62347/bouc4040
Citations
1
Primary Topic
Protein Degradation and Inhibitors
Type
article
Field-Weighted Citation Impact
0.81

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Upregulated PXDNL promotes invasive breast carcinoma progression

Xianping Zhou
1 citations
American Journal of Translational Research
Protein Degradation and Inhibitors
0.81
article

Upregulated PXDNL promotes invasive breast carcinoma progression

Xianping Zhou
article en
1 citations

Abstract

Overexpression of PXDNL is associated with poor prognosis and is linked to immune cell infiltration in BRCA. Thus, PXDNL may be a biomarker or therapeutic target for BRCA.

American Journal of Translational ResearchVol. 17(3)
Anhui Medical University (CN), Bozhou People's Hospital (CN), First Affiliated Hospital of Anhui Medical University (CN)
Anhui Medical University
Zero hunger
Openalex Percentile: Top 30%
Protein Degradation and Inhibitors
0.81
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Upregulated PXDNL promotes invasive breast carcinoma progression — Xianping Zhou · American Journal of Translational Research (2025) | TGRS Research Map | TGRS